Kirakoya B, Hounnasso P P, Pare A K, Mustapha A B, Zango B
Urology department, University Hospital Yalgado Ouedraogo, Ouagadougou, Burkina Faso.
Department of Urology, University Hospital of Cotonou, Republic of Benin.
J West Afr Coll Surg. 2014 Oct-Dec;4(4):70-81.
Prostate cancer is not uncommon in Burkina Faso and presents late, often advanced at presentation as is the case in most countries of West Africa.
To describe the clinical and histopathological characteristics of prostate cancer at the University Hospital Yalgado Ouedraogo, Burkina Faso.
PATIENTS & METHODS: We conducted a cross-sectional descriptive study of patients treated at the Urology Department of the University Hospital Yalgado Ouedraogo, Burkina Faso for prostate cancer from March 2012 to May 2013. The parameters studied were patients' demographics, clinical features, PSA, histological diagnosis, tumour grading, management and outcome.
In this study, 82 patients satisfied the inclusion criteria within the 15 months period of the study. The mean age was 68.9 years (standard deviation: 9.52) with a range of 49-95 years. They presented with symptoms of lower urinary tract obstruction in 57 (69.5%) patients, and irritative symptoms in 59 (72%) patients. At diagnosis 33 (40.2%) of patients had metastases and the most common metastatic sites were the spine in 18(21. 95%), the ribs in 6 (7.31%) and the pelvis in 5 (6.09%) patients. The mean PSA level was 746 ng/ml with a range of 13 - 9224ng /ml. Advanced T3 and T4 tumors accounted for 25.4% and 73.2% respectively. Adenocarcinoma was the only histological form. Gleason score was less than 7 in 41(49.4 %) cases. Androgen deprivation therapy (ADT) was the treatment for 79 (96.34%) patients. In all, 51 (62.19%) patients received medical ADT while 20 (24.39%) patients underwent bilateral orchiectomy. One patient underwent radical prostatectomy.
In this environment, prostate cancer is diagnosed at an advanced stage with distant metastasis. It is therefore useful to develop effective screening policy for early detection and better outcome of management.
前列腺癌在布基纳法索并不罕见,且发现时往往较晚,通常在就诊时已处于晚期,西非大多数国家的情况都是如此。
描述布基纳法索亚尔加杜·韦德拉奥果大学医院前列腺癌的临床和组织病理学特征。
我们对2012年3月至2013年5月期间在布基纳法索亚尔加杜·韦德拉奥果大学医院泌尿外科接受前列腺癌治疗的患者进行了一项横断面描述性研究。研究的参数包括患者的人口统计学特征、临床特征、前列腺特异性抗原(PSA)、组织学诊断、肿瘤分级、治疗及结果。
在本研究中,82例患者在15个月的研究期内符合纳入标准。平均年龄为68.9岁(标准差:9.52),年龄范围为49至95岁。57例(69.5%)患者出现下尿路梗阻症状,59例(72%)患者出现刺激性症状。诊断时,33例(40.2%)患者已有转移,最常见的转移部位是脊柱,有18例(21.95%);肋骨,有6例(7.31%);骨盆,有5例(6.09%)。PSA平均水平为746 ng/ml,范围为13至9224 ng/ml。晚期T3和T4肿瘤分别占25.4%和7...2%。腺癌是唯一的组织学类型。41例(49.4%)病例的 Gleason评分低于7分。79例(96.34%)患者接受了雄激素剥夺治疗(ADT)。其中,51例(62.19%)患者接受了药物ADT,20例(24.39%)患者接受了双侧睾丸切除术。1例患者接受了前列腺根治术。
在这种情况下,前列腺癌在诊断时已处于晚期并伴有远处转移。因此,制定有效的筛查政策以实现早期发现并改善治疗效果是很有必要的。